These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24900446)

  • 1. Virtual Screening and X-ray Crystallography for Human Kallikrein 6 Inhibitors with an Amidinothiophene P1 Group.
    Liang G; Chen X; Aldous S; Pu SF; Mehdi S; Powers E; Giovanni A; Kongsamut S; Xia T; Zhang Y; Wang R; Gao Z; Merriman G; McLean LR; Morize I
    ACS Med Chem Lett; 2012 Feb; 3(2):159-64. PubMed ID: 24900446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human kallikrein 6 inhibitors with a para-amidobenzylanmine P1 group identified through virtual screening.
    Liang G; Chen X; Aldous S; Pu SF; Mehdi S; Powers E; Xia T; Wang R
    Bioorg Med Chem Lett; 2012 Apr; 22(7):2450-5. PubMed ID: 22386244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of recombinant human tissue kallikrein at 2.0 A resolution.
    Katz BA; Liu B; Barnes M; Springman EB
    Protein Sci; 1998 Apr; 7(4):875-85. PubMed ID: 9568894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X-ray structures of human neutrophil collagenase complexed with peptide hydroxamate and peptide thiol inhibitors. Implications for substrate binding and rational drug design.
    Grams F; Reinemer P; Powers JC; Kleine T; Pieper M; Tschesche H; Huber R; Bode W
    Eur J Biochem; 1995 Mar; 228(3):830-41. PubMed ID: 7737183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based drug design of 1,3,6-trisubstituted 1,4-diazepan-7-ones as selective human kallikrein 7 inhibitors.
    Murafuji H; Sakai H; Goto M; Oyama Y; Imajo S; Sugawara H; Tomoo T; Muto T
    Bioorg Med Chem Lett; 2018 May; 28(8):1371-1375. PubMed ID: 29550094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A structural model for the prostate disease marker, human prostate-specific antigen.
    Villoutreix BO; Getzoff ED; Griffin JH
    Protein Sci; 1994 Nov; 3(11):2033-44. PubMed ID: 7535613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of HIV-1 protease inhibitors with pyrrolidinones and oxazolidinones as novel P1'-ligands to enhance backbone-binding interactions with protease: synthesis, biological evaluation, and protein-ligand X-ray studies.
    Ghosh AK; Leshchenko-Yashchuk S; Anderson DD; Baldridge A; Noetzel M; Miller HB; Tie Y; Wang YF; Koh Y; Weber IT; Mitsuya H
    J Med Chem; 2009 Jul; 52(13):3902-14. PubMed ID: 19473017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structures of the complex of a kallikrein inhibitor from Bauhinia bauhinioides with trypsin and modeling of kallikrein complexes.
    Li M; Srp J; Gustchina A; Dauter Z; Mares M; Wlodawer A
    Acta Crystallogr D Struct Biol; 2019 Jan; 75(Pt 1):56-69. PubMed ID: 30644845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The most potent organophosphorus inhibitors of leucine aminopeptidase. Structure-based design, chemistry, and activity.
    Grembecka J; Mucha A; Cierpicki T; Kafarski P
    J Med Chem; 2003 Jun; 46(13):2641-55. PubMed ID: 12801228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new structural class of serine protease inhibitors revealed by the structure of the hirustasin-kallikrein complex.
    Mittl PR; Di Marco S; Fendrich G; Pohlig G; Heim J; Sommerhoff C; Fritz H; Priestle JP; Grütter MG
    Structure; 1997 Feb; 5(2):253-64. PubMed ID: 9032072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of plasma kallikrein reveals the unusual flexibility of the S1 pocket triggered by Glu217.
    Xu M; Chen Y; Xu P; Andreasen PA; Jiang L; Li J; Huang M
    FEBS Lett; 2018 Aug; 592(15):2658-2667. PubMed ID: 30019481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The structure of human prokallikrein 6 reveals a novel activation mechanism for the kallikrein family.
    Gomis-Rüth FX; Bayés A; Sotiropoulou G; Pampalakis G; Tsetsenis T; Villegas V; Avilés FX; Coll M
    J Biol Chem; 2002 Jul; 277(30):27273-81. PubMed ID: 12016211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, X-ray crystallography, and infected T-cell assays.
    Dreyer GB; Lambert DM; Meek TD; Carr TJ; Tomaszek TA; Fernandez AV; Bartus H; Cacciavillani E; Hassell AM; Minnich M
    Biochemistry; 1992 Jul; 31(29):6646-59. PubMed ID: 1637805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (4-aminomethyl)phenylguanidine derivatives as nonpeptidic highly selective inhibitors of human urokinase.
    Sperl S; Jacob U; Arroyo de Prada N; Stürzebecher J; Wilhelm OG; Bode W; Magdolen V; Huber R; Moroder L
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5113-8. PubMed ID: 10805774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-ray structure of a novel matrix metalloproteinase inhibitor complexed to stromelysin.
    Dunten P; Kammlott U; Crowther R; Levin W; Foley LH; Wang P; Palermo R
    Protein Sci; 2001 May; 10(5):923-6. PubMed ID: 11316871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Halothiophene benzimidazoles as P1 surrogates of inhibitors of blood coagulation factor Xa.
    Mederski WW; Dorsch D; Anzali S; Gleitz J; Cezanne B; Tsaklakidis C
    Bioorg Med Chem Lett; 2004 Jul; 14(14):3763-9. PubMed ID: 15203158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonpeptidic potent HIV-1 protease inhibitors: (4-hydroxy-6-phenyl-2-oxo-2H- pyran-3-yl)thiomethanes that span P1-P2' subsites in a unique mode of active site binding.
    Prasad JV; Para KS; Tummino PJ; Ferguson D; McQuade TJ; Lunney EA; Rapundalo ST; Batley BL; Hingorani G; Domagala JM
    J Med Chem; 1995 Mar; 38(6):898-905. PubMed ID: 7699705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonpolar interactions of thrombin S' subsites with its bivalent inhibitor: methyl scan of the inhibitor linker.
    Slon-Usakiewicz JJ; Purisima E; Tsuda Y; Sulea T; Pedyczak A; Féthière J; Cygler M; Konishi Y
    Biochemistry; 1997 Nov; 36(44):13494-502. PubMed ID: 9354617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the enzymatic activity of human kallikrein 6: Autoactivation, substrate specificity, and regulation by inhibitors.
    Magklara A; Mellati AA; Wasney GA; Little SP; Sotiropoulou G; Becker GW; Diamandis EP
    Biochem Biophys Res Commun; 2003 Aug; 307(4):948-55. PubMed ID: 12878203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applications.
    Diamandis EP; Yousef GM; Soosaipillai AR; Grass L; Porter A; Little S; Sotiropoulou G
    Clin Biochem; 2000 Jul; 33(5):369-75. PubMed ID: 11018688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.